The bill establishes new regulations for the sale and distribution of hemp-derived cannabinoid products in Kansas, defining key terms such as "approved source," "child-resistant," and "hemp-derived cannabinoid product." It mandates that all products sold in retail must originate from an approved source, be properly packaged and labeled, and have a valid certificate of analysis available upon request. The legislation prohibits sales to individuals under 21 and requires specific labeling that includes product origin and manufacturer contact information, while also restricting packaging from featuring cartoon images or branding appealing to children. Additionally, the bill amends existing laws related to industrial hemp, clarifying definitions and establishing guidelines for production and processing, with penalties for violations.

Furthermore, the bill revises definitions related to controlled substances, including "immediate precursor," "manufacture," and "marijuana," while introducing new terms such as "readily retrievable" and "ultimate user." It emphasizes the importance of electronic prescriptions and outlines the responsibilities of prescribers and pharmacies in managing these prescriptions. The bill also repeals several existing statutes, specifically K.S.A. 2-3908 and K.S.A. 2024 Supp. 2-3901, 21-5701, and 65-4101, and will take effect immediately upon publication in the statute book. Overall, the legislation aims to enhance consumer safety and regulatory compliance within the hemp and controlled substances sectors.

Statutes affected:
As introduced: 2-3901, 2-3908, 21-5701, 65-4101